Read More 1 minute read Analyst Ratings Downgrades News Stephens & Co. Downgrades Ping Identity Holding to Equal-Weight By Benzinga Newsdesk August 4, 8:14 AM Stephens & Co. analyst Brian Colley downgrades Ping Identity Holding (NYSE:PING) from Overweight to Equal-Weight. PING
Read More 1 minute read Analyst Ratings Downgrades News Raymond James Downgrades NexPoint Residential to Market Perform By Benzinga Newsdesk August 4, 7:30 AM Raymond James analyst Buck Horne downgrades NexPoint Residential (NYSE:NXRT) from Outperform to Market Perform. NXRT
Read More 1 minute read Analyst Ratings Downgrades News Raymond James Downgrades Centerspace to Market Perform By Benzinga Newsdesk August 4, 7:26 AM Raymond James analyst Buck Horne downgrades Centerspace (NYSE:CSR) from Outperform to Market Perform. CSR
Read More 1 minute read Analyst Ratings Downgrades News Price Target Cowen & Co. Downgrades Kohl’s to Market Perform, Lowers Price Target to $35 By Benzinga Newsdesk August 4, 6:34 AM Cowen & Co. analyst Oliver Chen downgrades Kohl's (NYSE:KSS) from Outperform to Market Perform and lowers the price target from $60 to $35. KSS
Read More 1 minute read Analyst Ratings Downgrades News Price Target BMO Capital Downgrades Warrior Met Coal to Market Perform, Lowers Price Target to $37 By Benzinga Newsdesk August 4, 6:29 AM BMO Capital analyst David Gagliano downgrades Warrior Met Coal (NYSE:HCC) from Outperform to Market Perform and lowers the price target from $45 to $37. HCC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Baird Downgrades Under Armour to Neutral, Announces $10 Price Target By Benzinga Newsdesk August 4, 6:27 AM Baird analyst Jonathan Komp downgrades Under Armour (NYSE:UAA) from Outperform to Neutral and announces $10 price target. UA
Read More 1 minute read Analyst Ratings Downgrades News Price Target Jefferies Downgrades Medifast to Hold, Lowers Price Target to $150 By Benzinga Newsdesk August 4, 6:23 AM Jefferies analyst Stephanie Wissink downgrades Medifast (NYSE:MED) from Buy to Hold and lowers the price target from $345 to $150. MED
Read More 1 minute read Analyst Ratings Downgrades News Price Target Morgan Stanley Downgrades Levi Strauss to Equal-Weight, Announces $19 Price Target By Benzinga Newsdesk August 4, 6:21 AM Morgan Stanley analyst Kimberly Greenberger downgrades Levi Strauss (NYSE:LEVI) from Overweight to Equal-Weight and announces $19 price target. LEVI
Read More 1 minute read Analyst Ratings Downgrades News Price Target Piper Sandler Downgrades Trupanion to Neutral, Lowers Price Target to $69 By Benzinga Newsdesk August 4, 6:19 AM Piper Sandler analyst John Barnidge downgrades Trupanion (NASDAQ:TRUP) from Overweight to Neutral and lowers the price target from $80 to $69. TRUP
Read More 1 minute read Analyst Ratings Downgrades News Price Target Truist Securities Downgrades Match Group to Hold, Lowers Price Target to $68 By Benzinga Newsdesk August 3, 3:55 PM Truist Securities analyst Youssef Squali downgrades Match Group (NASDAQ:MTCH) from Buy to Hold and lowers the price target from $145 to $68. MTCH